Factors associated with changes in tacrolimus blood concentration after food initiation in patients with ulcerative colitis.

IF 1.5 4区 医学 Q4 CHEMISTRY, MEDICINAL Pharmazie Pub Date : 2024-06-01 DOI:10.1691/ph.2024.4501
N Yoshikawa, T Nagatomo, Y Matsusaki, T Yokota, Y Yamada, R Ikeda
{"title":"Factors associated with changes in tacrolimus blood concentration after food initiation in patients with ulcerative colitis.","authors":"N Yoshikawa, T Nagatomo, Y Matsusaki, T Yokota, Y Yamada, R Ikeda","doi":"10.1691/ph.2024.4501","DOIUrl":null,"url":null,"abstract":"<p><p>The therapeutic effect of tacrolimus against ulcerative colitis (UC) is correlated with its trough blood concentration. Conventionally, oral tacrolimus for the treatment of UC is initiated under fasting conditions; once the symptoms improve, food intake is resumed. Tacrolimus blood concentration decreases with food intake compared with that under fasting conditions. The aim of this study was to explore the characteristics of patients with UC whose tacrolimus blood concentrations tended to decrease after food initiation. Medical data of 13 patients with UC and treated with tacrolimus were retrospectively obtained. The participant characteristics associated with the changes in tacrolimus blood concentrations after food initiation were analyzed using regression analysis based on the rate of decrease in the concentration/dose (C/D) ratio after food initiation. Single regression analysis showed that the number of days required from tacrolimus initiation to food resumption (<i>P</i> = 0.0071) and individual differences in the increase in tacrolimus blood concentration after administration (<i>P</i> = 0.0247) were significantly associated with the rate of decrease in the C/D ratio after food initiation. Furthermore, multiple regression analysis showed a significant effect of the number of days to food resumption (<i>P</i> = 0.0004) and individual differences in the increase in tacrolimus blood concentration after administration (<i>P</i> = 0.0012). The results suggest that the degree of change in blood tacrolimus concentration after food initiation may be related to the severity of the symptoms and pathology of UC. Early identification of participant characteristics may help control tacrolimus blood concentration fluctuations after food initiation.</p>","PeriodicalId":20145,"journal":{"name":"Pharmazie","volume":null,"pages":null},"PeriodicalIF":1.5000,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pharmazie","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1691/ph.2024.4501","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
引用次数: 0

Abstract

The therapeutic effect of tacrolimus against ulcerative colitis (UC) is correlated with its trough blood concentration. Conventionally, oral tacrolimus for the treatment of UC is initiated under fasting conditions; once the symptoms improve, food intake is resumed. Tacrolimus blood concentration decreases with food intake compared with that under fasting conditions. The aim of this study was to explore the characteristics of patients with UC whose tacrolimus blood concentrations tended to decrease after food initiation. Medical data of 13 patients with UC and treated with tacrolimus were retrospectively obtained. The participant characteristics associated with the changes in tacrolimus blood concentrations after food initiation were analyzed using regression analysis based on the rate of decrease in the concentration/dose (C/D) ratio after food initiation. Single regression analysis showed that the number of days required from tacrolimus initiation to food resumption (P = 0.0071) and individual differences in the increase in tacrolimus blood concentration after administration (P = 0.0247) were significantly associated with the rate of decrease in the C/D ratio after food initiation. Furthermore, multiple regression analysis showed a significant effect of the number of days to food resumption (P = 0.0004) and individual differences in the increase in tacrolimus blood concentration after administration (P = 0.0012). The results suggest that the degree of change in blood tacrolimus concentration after food initiation may be related to the severity of the symptoms and pathology of UC. Early identification of participant characteristics may help control tacrolimus blood concentration fluctuations after food initiation.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
溃疡性结肠炎患者开始进食后他克莫司血药浓度变化的相关因素。
他克莫司对溃疡性结肠炎(UC)的治疗效果与其血药浓度谷值相关。传统上,口服他克莫司治疗溃疡性结肠炎是在禁食的情况下开始的;一旦症状改善,就恢复进食。与禁食条件下相比,他克莫司的血药浓度会随着进食而降低。本研究旨在探讨进食后他克莫司血药浓度呈下降趋势的 UC 患者的特征。研究人员回顾性获取了 13 名接受他克莫司治疗的 UC 患者的医疗数据。根据进食后他克莫司血药浓度/剂量(C/D)比值的下降率,采用回归分析法分析了与进食后他克莫司血药浓度变化相关的参与者特征。单次回归分析表明,从开始服用他克莫司到恢复进食所需的天数(P = 0.0071)和给药后他克莫司血药浓度增加的个体差异(P = 0.0247)与开始进食后 C/D 比值的下降率显著相关。此外,多元回归分析表明,恢复进食的天数(P = 0.0004)和给药后他克莫司血药浓度增加的个体差异(P = 0.0012)有显著影响。结果表明,开始进食后血液中他克莫司浓度的变化程度可能与 UC 症状和病理的严重程度有关。及早识别参与者的特征可能有助于控制进食后他克莫司血药浓度的波动。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Pharmazie
Pharmazie 医学-化学综合
CiteScore
3.10
自引率
0.00%
发文量
56
审稿时长
1.2 months
期刊介绍: The journal DiePharmazie publishs reviews, experimental studies, letters to the editor, as well as book reviews. The following fields of pharmacy are covered: Pharmaceutical and medicinal chemistry; Pharmaceutical analysis and drug control; Pharmaceutical technolgy; Biopharmacy (biopharmaceutics, pharmacokinetics, biotransformation); Experimental and clinical pharmacology; Pharmaceutical biology (pharmacognosy); Clinical pharmacy; History of pharmacy.
期刊最新文献
Analysis and evaluation of factors contributing to the occurrence of immune-related adverse events with immune checkpoint inhibitors. Effect of genetic factors on the interindividual variability of warfarin dosage requirements in Japanese patients after adjusting for renal function. Investigations on 5,6,7,8-tetrahydro-[1,2,4]triazolo[1,2-a]pyridazin-1-amines and related compounds: synthesis, chemical behaviour, structure elucidation and iNOS inhibitory activity. Management of apixaban anticoagulation in a patient requiring therapeutic plasma exchange: a case report and a literature review. Metabolism of baicalin by different microbiota determined by MimiCol.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1